New England Journal of Medicine 366: 1181-9 (March 29, 2012)
Friday, March 30, 2012 - 16:40
in Health & Medicine
New England Journal of Medicine 366: 1181-9 Brodalumab, an anti–interleukin-17–receptor antibody for psoriasis Kim A. Papp, Craig Leonardi, Alan Menter, Jean-Paul Ortonne, James G. Krueger, Gregory Kricorian, Girish Aras, Juan Li, Chris B. Russell, Elizabeth H.Z. Thompson, and Scott Baumgartner … More »
Read the whole article on The Rockefeller University
More from The Rockefeller University
Related
- Research shows treating HIV-AIDS with interleukin-2 is ineffectiveThu, 15 Oct 2009, 19:09:31 EDT
- Monitoring whether patients take medicines can help anticipate HIV treatment failure in AfricaTue, 20 May 2008, 8:07:33 EDT
- Irish-led research team rule out link between specific antibodies and spina bifidaWed, 8 Jul 2009, 17:29:40 EDT
- Traumatic aortic injury -- New England Journal of Medicine reviewWed, 15 Oct 2008, 17:42:47 EDT
- New England Journal of Medicine publishes Mayo Clinic study about health care reformThu, 24 Sep 2009, 12:42:56 EDT